This is not the most recent version of the article. View current version (6 JUN 2013)

Intervention Protocol

Selenium supplementation for Hashimoto's thyroiditis

  1. Amira Y Albusta1,
  2. Esther J van Zuuren2,*,
  3. Zbys Fedorowicz3,
  4. Ben Carter4,
  5. Hanno Pijl5,
  6. Amani Al Hajeri6

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD010223

How to Cite

Albusta AY, van Zuuren EJ, Fedorowicz Z, Carter B, Pijl H, Al Hajeri A. Selenium supplementation for Hashimoto's thyroiditis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010223. DOI: 10.1002/14651858.CD010223.

Author Information

  1. 1

    AMA International University of Bahrain, College of Medicine, Manama, Bahrain

  2. 2

    Leiden University Medical Center, Department of Dermatology, Leiden, Netherlands

  3. 3

    The Cochrane Collaboration, UKCC (Bahrain Branch), Awali, Bahrain

  4. 4

    Bangor University, North Wales Centre for Primary Care Research, Wrexham, UK

  5. 5

    Leiden University Medical Centre, Department of Endocrinology, Leiden, Netherlands

  6. 6

    Ministry of Health, Department of Genetics, Awali, Bahrain

*Esther J van Zuuren, Department of Dermatology, Leiden University Medical Center, PO Box 9600, B1-Q, Leiden, 2300 RC, Netherlands. E.J.van_Zuuren@lumc.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (06 JUN 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of selenium supplementation for Hashimoto's thyroiditis.